The financials
Novartis AG by the numbers
Novartis AG (NVS) reported revenue of $27.2B in H2 2025 (quarter ended December 31, 2025), up 118% from the same quarter a year earlier. That came with a gross margin of 77% and net income of $6.34B (23% of revenue). For the full year FY2025, revenue was $54.5B (+8.4% year on year) and net income $14.0B.
| Income statement | H2 2025 | Q2 2024 | Change |
|---|---|---|---|
| Revenue | $27.2B | $12.5B | +118% |
| Gross profit | $21.1B | $9.70B | +117% |
| Operating income | $8.12B | $4.01B | +102% |
| Net income | $6.34B | $3.25B | +95% |
| Diluted EPS | $3.27 | $1.59 | +106% |
Drug Manufacturers - General
Ranks #10 of 16 by Smart Score